Five-Year Results With Patisiran for Hereditary Transthyretin Amyloidosis With PolyneuropathyDavid Adams, Mónica Freitas, Jonas Wixner et al.|JAMA Neurology|2025Cited by 34
Impact of Vutrisiran on Quality of Life and Physical Function in Patients with Hereditary Transthyretin-Mediated Amyloidosis with PolyneuropathyLaura Obici, Conceição de Azevedo Coutinho, Julian D. Gillmore et al.|Neurology and Therapy|2023Cited by 21